← Open Payments lookup

LAWRENCE MORA: Open Payments

NPI 1205851615 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$970 in 44 payments from 13 companies in 2025. Trend: 2023 $1,069 · 2024 $1,032 · 2025 $970

Food & beverage: $970
CompanyPaymentsAmount
Indivior Inc.8$213
AstraZeneca Pharmaceuticals LP8$201
GlaxoSmithKline, LLC.8$146
Amgen Inc.4$86
Almatica Pharma LLC4$77
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$42
ABBVIE INC.2$41
Otsuka America Pharmaceutical, Inc.2$36
Novo Nordisk Inc2$35
Alkermes, Inc.1$28

Products named: SUBLOCADE, BREZTRI, TRELEGY ELLIPTA, LOREEV XR, OTEZLA, XIFAXAN, REXULTI, Rybelsus.

Industry payments across CA — which companies pay providers there.